1. Home /
  2. Health

Health

Time to Check Out Ebix

EBIX offers extensive potential gains while downside appears small.

Cannabis Companies Eyeing How Plant Could Help Autism Symptoms

After finding success in treatment for epilepsy and other conditions, some in the industry are focusing on autism spectrum disorder.

This Dividend Stock Is Good for Both Waistline and Bottom Line

As obesity rates climb higher, the quarterly dividend of Medifast should, too.

Cannabis Company Eyes Medicinal Magic of Mushrooms

Mydecine Innovations Group -- formerly known as NewLeaf -- signed an agreement with the University of Alberta's Faculty of Pharmacy and Pharmaceutical Sciences.

Jim Cramer: This Is a Brave New Economy We're In

The Fed and Treasury are set on avoiding the mistakes that doomed us in the past, and we have to invest for this new market we're in now.

Jim Cramer: The Cost of Staying Closed

We can't wait for a vaccine, but we can follow logical guidelines for staying as safe as possible, helping us avoid another Great Depression.

Investors Waking Up to New Cannabis Opportunity: Sleep Aids

Studies appear to back up some cannabis products' use in helping users catch needed z's.

Zimmer Biomet Holdings Is Only Temporarily Out of Joint

Focus on coronavirus patients has hospitals deferring elective surgeries, but eventually patients who need knee, hip and other replacements will be back on surgical schedules.

Jim Cramer: Here's the Science Behind Our Rally

While Johnson & Johnson and other pharma cos. give us hope, here's my wish list to keep the nation safe and the economy ready to go again.

Good Medicine for a Retest? Johnson & Johnson

A strong S&P for three days makes me leery of what's ahead, but here's an option in JNJ.